TrialEuropean journal of medical research2009

A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis.

N Dauletbaev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.